BiotechTube
Home/Hsiri Therapeutics/Marvin Miller, Ph.D.
MM

Marvin Miller, Ph.D.

Chief Scientific Officer

Hsiri Therapeutics

Therapeutic Areas

Infectious DiseasesMycobacterial InfectionsAntimicrobial Resistance

Hsiri Therapeutics Pipeline

DrugIndicationPhase
Mycobacterial Diseases ProgramTuberculosis (TB) and Non-Tuberculous Mycobacterial (NTM) InfectionsPre-clinical
Drug-Resistant Bacterial Infections ProgramInfections due to usual bacterial pathogens resistant to current treatmentsResearch/Pre-clinical
Drug-Resistant Fungal Infections ProgramInfections due to drug-resistant fungal pathogensResearch/Pre-clinical

Leadership Team at Hsiri Therapeutics

WC
William Claypool, M.D.
Chairman and CEO
IJ
Ivan Joseph, MBA
Chief Financial Officer
CF
Carrie Frey, MSC, MBA
Chief Operating Officer
View full Hsiri Therapeutics profile